CanSino Biologics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-378.88	-1,483	-909.43	1,914
Depreciation & Amortization	195.25	263.24	189.22	73.36
Other Amortization	21.58	6.3	7.14	15.18
Loss (Gain) From Sale of Assets	0.02	-0.02	-	-
Asset Writedown & Restructuring Costs	1.32	362.7	0.25	0.25
Loss (Gain) From Sale of Investments	43.1	-42.63	-76.63	-71.86
Stock-Based Compensation	3.2	9.54	10.08	9.8
Provision & Write-off of Bad Debts	15.15	15.05	8.78	1.82
Other Operating Activities	60.26	139.98	624.87	-6.58
Change in Accounts Receivable	-78.56	265.97	-495.8	-419.94
Change in Inventory	-0.68	-216.54	-604.02	-706.39
Change in Accounts Payable	-106.27	-223.19	-429.93	1,212
Change in Unearned Revenue	54.38	-5.64	20.88	27.52
Change in Other Net Operating Assets	0.38	11.2	-	-
Operating Cash Flow	-167.29	-908.23	-1,852	2,050
Capital Expenditures	-457.64	-610.47	-1,075	-1,203
Sale of Property, Plant & Equipment	0.04	0.31	-	-
Cash Acquisitions	-1.31	-0.34	-	-
Investment in Securities	377.48	99.25	-697.83	-1,403
Other Investing Activities	83.89	61.59	545.21	45.77
Investing Cash Flow	2.46	-449.65	-1,228	-2,560
Short-Term Debt Issued	-	50.46	-	-
Long-Term Debt Issued	1,043	1,635	2,634	1,150
Total Debt Issued	1,043	1,685	2,634	1,150
Short-Term Debt Repaid	-	-20.58	-	-
Long-Term Debt Repaid	-1,314	-1,615	-1,388	-181
Total Debt Repaid	-1,314	-1,636	-1,388	-181
Net Debt Issued (Repaid)	-270.47	49.32	1,246	969.13
Issuance of Common Stock	-	16.98	-	-
Repurchase of Common Stock	-	-	-150.17	-
Common Dividends Paid	-63.78	-73.75	-241.28	-14.1
Other Financing Activities	0.07	-0.14	-0.37	598.59
Financing Cash Flow	-334.18	-7.58	854.23	1,554
Foreign Exchange Rate Adjustments	8.72	20.29	160.76	-33.78
Net Cash Flow	-490.29	-1,345	-2,064	1,009
Free Cash Flow	-624.93	-1,519	-2,927	846.86
Free Cash Flow Margin	-73.84%	-425.31%	-282.87%	19.70%
Free Cash Flow Per Share	-2.52	-6.16	-11.84	3.42
Cash Income Tax Paid	25.19	-24.05	-77.91	-162.45
Levered Free Cash Flow	-860.93	-908.45	-2,557	185.99
Unlevered Free Cash Flow	-823.44	-868.36	-2,531	198.76
Change in Working Capital	-128.3	-179.65	-1,706	113.64

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.